Recent surveys of the use of primates in biomedical laboratories indicate that the demand, especially for imported animals, is declining. Reasons for this trend are not clear, although restrictions on export by countries of origin undoubtedly have a significant effect. More precise survey techniques and terminology would aid comparisons and help to identify the factors involved in changes in demand.
Summary
Recent surveys of the use of primates in biomedical laboratories indicate that the demand, especially for imported animals, is declining. Reasons for this trend are not clear, although restrictions on export by countries of origin undoubtedly have a significant effect. More precise survey techniques and terminology would aid comparisons and help to identify the factors involved in changes in demand.
A number of recent surveys (Hobbs & Bleby, 1976; Honjo & Nomura, 1972; ILAR, 1975) have resulted in recommendations on the feasibility of breeding primates, and of improving the way in which wild primates are captured and then handled during transport and quarantine. As the supply of these animals from their countries of origin decreases, it will become increasingly important to put these recommendations into practice if the present level of primate use is to be maintained. Where researchers are asked for projected demand figures, they invariably require more primates than are currently available or being used. However, it is conceivable that the demand for primates could be reduced through the search for and development of adequate alternative models.
At FRAME (Fund for the Replacement of Animals in Medical Experiments), a survey is currently underway to investigate the use of primates in biomedical programmes in order to identify those areas where the primate model may be inadequate, and to explore the potential for developing practical alternative systems. Here an 'alternative' is defined as any system which could reduce the demand for laboratory animals while producing information of comparable value. This paper presents the 1st stage of the survey as a review of the literature to determine the trends in primate availability and use. The review has highlighted several discrepancies in the figures available, and it identifies some of the problems involved in attempting to compare use and availability between different countries and different years.
Wbat is a primate? As far as possible, the Tables in this report have been compiled on the basis of the classification of the Order Primates proposed by Napier & Napier (1967) Suborders, the Prosimii (including the tarsiers, lemurs, tree-shrews and galagos) and the Anthropoidea (including the anthropoid apes, New World monkeys, Old World monkeys, and man-who is not included in this report).
In the UK, another widely accepted classification scheme is that of Rothschild (see Hobbs & Bleby, 1976) who puts tarsiers into the separate Suborder Tarsii. Some authorities omit tree-shrews from the order altogether, while the US Department of Agriculture lists all prosimians with 'other wild animals'. The discrepancies caused by these different classifications is usually small, but it is important to be aware of the situation. t Number of animals requested on licences issued (imports about 50%).
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Imports and legislation in user countries
This report is concerned with imports specifically for biomedical use, but unfortunately some import totals also cover primates destined for re-export, breeding units, exhibition, pet trade, and include those which die in quarantine. Sometimes the numbers of primates imported for scientific research can be estimated. Table 2 shows the number of primates imported annually into the UK, USA and Japan from 1964. In the preceding 15 years there had been dramatic fluctuations in demand. At the end of the 1940s, the demand for primates as laboratory animals was very low. With the expansion of the research effort devoted to finding a vaccine to combat polio (poliomyelitis), the demand for primate tissue grew and in the late 1950s the US was importing 200000 rhesus monkeys annually from India alone (Hartley, 1972) . As research progressed techniques improved and production methods standardized (using mainly seriallycultivated human diploid cell lines), the demand for monkeys fell. However, research workers began to use the numerous primates available to investigate a wider range of problems. Thefore the numbers required were still substantially higher than prior to the polio research effort, although several countries of origin, notably India, have steadily reduced their export quotas or halted export of certain species altogether.
The situation in the UK
The completeness of import records depends on the legislation in force and the enthusiasm of the government department in charge at the time. The Animals (Restriction of Importation) Act of 1964 controlled imports until 1976. Most primates entering the UK were subject to import licences issued by the Board of Trade, but enforcement was the responsibility of HM Customs and Excise. Reports of the Advisory Committee to the Board were the responsibility of the Department of Education and Science until 1 November 1973, when the Department of the Environment took over. Between 1964 and 1967 it is only possible to obtain a figure for the number of animals specified on the licences issued. Not all of these animals were actually imported-probably about half the number given on the licences were actually received (K. R. Hobbs, personal communication, 1978) . This discrepancy has been misleading, as can be seen from ILAR (1975) , which mistakenly concluded that primate demand in the UK dropped by 50% between 1967 and 1971 (see Table 2 ). The actual number of animals requested on licences issued in 1971 was 16 350 (Department of the Environment, 1975 Imports are also controlled by the Rabies (Importation of Dogs, Cats and other Mammals) Order 1974, following similar legislation which had been in force since 1969. This Order prohibits the import of a wide range of species, including all primates, except to premises approved by the Ministry of Agriculture, Fisheries and Food, and it has been responsible for improving the husbandry and handling of primates in the UK to a generally high standard. However, it is difficult to obtain any import figures under this Order, and the Ministry only produced the 1975 figure at great effort in response to a parliamentary question (J. A. Burton, personal communication, 1978) . It is interesting to note that the figure is much higher than that issued by the Department of the Environment. This is probably because the Animals (Restriction oj Importation) Act 1964 did not include the families Tupaidae and Lorisidae (tree-shrews and galagos). As monkeys become harder to obtain, the importance of these pro simians is likely to increase.
A comparison of total imports with imports specified for scientific research shows that very few primates are now imported for the pet trade, exhibition or resale. The impact of the legislation in decreasing the risk of introducing rabies into Britain is obvious from the figures for 1971 which show a marked reduction in primate imports for scientific research alone. Even before this time the pet trade had in fact been small, and the category 'resale' accounted for most of the difference.
British legislation to protect primates and other animals has affected species composition of import figures. Burton (1978) has examined the imports from [1965] [1966] [1967] [1968] [1969] [1970] [1971] [1972] [1973] [1974] [1975] , which indicate that as one species is depleted, and consequently protected, the demand shifts to others. 
animals-monkeys
and other primates'. However, primates are also placed under another category ('Wild animals imported for use, or for sale for use in any scientific public collection for exhibition, or for scientific or educational purposes') which does not identify the species (Muckenhirn, 1975) .
It is not clear why the 2 sets of figures from the USDI should differ. The Bureau of Sport, Fisheries and Wildlife published reports on wildlife imports based on information supplied in declarations for importation filed with US Customs officers (USDI, 1972) . The mammals imported into the US from 1968 to 1972 were listed by species in several other reports by the same agency, presumably using the same information. (Clapp, 1972) .
All the figures in Table 2 refer to total imports, but ILAR (1975) estimated that only 55 000 of the 69548 primates imported into the USA in 1973 were destined for use in biomedical programmes. It is interesting to note that they estimated that 67 900 primates were actually maintained in laboratories during the same period.
The situation in Japan Japan's import figures are particularly interesting, especially for the years 1970-1974. It is not clear why there should have been such a sharp and short-lived increase in primates imported, especially since Japan has its own source of wild primates, notably Macaca fascata, the Japanese macaque. Except for the years 1966 and 1972, where there appears to have been a simple arithmetic or typographical error, the figures given from 1964 to 1975 are quite close. These were supposedly based on official import figures, but the Japanese Embassy in London could only supply figures for 1976 and 1977. In Japan, the import of animals is the responsibility of the Department of Health and Social Security, but the Department of Agriculture keeps official import figures (Japanese Embassy, London, personal communication, 1978) .
Exports
The situation in the countries oj primate origin During 1973, several of the major exporting countries imposed further restrictions on the numbers of primates exported. The effect of these actions is seen quite clearly in the figures supplied by the 'USDC, which show a 40% reduction in imports between 1972 and 1974. This was mainly caused by changes in the South American trade when Peru and Columbia reduced the numbers of primates exported to 8 and 14% respectively of their 1972 levels (Muckenhirn, 1975) . The impact was felt in the pet trade where marmosets and other New World species were very popular. Rhesus macaques and other Old World species were used mainly in biomedical programmes and, although there has not been such a dramatic change in these figures, India did reduce her export quota for rhesus to 30 000 in 1974 (Muckenhirn, 1975) . According to a later report by Muckenhirn (1977) , only 11 000 rhesus were imported in 1976, and recently the Indian Government has banned all future export of these primates after April 1978 (Wade, 1978) .
Of those countries which do have major restrictions on primate export, few (if any) have total bans. It is still possible to obtain some primates for biomedical programmes from Peru, Brazil and Columbia-but only with the appropriate licences. 239 very low in relation to imports, but they are based on a survey of only 23 research instititions. However, such a survey is useful to observe trends and indicates a slight decline in the purchase of primates from 1967 to 1971.
The European figures come from a quick survey conducted by Hobbs (1975) , when researchers were asked to supply information on both the turnover and application to experiments of primates. It is interesting to compare the turnover figures for 1973 and 1974 with the total application figures for those years, which appear in Table 4 . For most countries they are similar, but Denmark's turnover figures are far greater than Table 3 . Numbers of primates replaced annually in biomedical programmes in Europe and Japan For Japan, numbers of primates purchased by 23 major institutions-including universities, private laboratories and pharmaceutical companies (Honjo & Nomura, 1972) .For European countries, numbers annually turned over; the 1975 figures are predictions (Hobbs, 1975) .
Japan UK Denmark Belgium France Germany Holland Italy Switzerland
Laboratory use of primates As already mentioned, this can refer to replacement, maintenance or experimental application of primates. Replacement may occur either from indigenous breeding programmes and wild populations, or from imports. As a result of increasing restrictions on the export of wild-caught primates, it is estimated that captive-bred animals will playa much larger role in the future. Scientifically this is more satisfactory, since the animals are of known pedigree and disease history, and external factors can therefore be controlled with greater precision. Table 3 lists the number of primates replaced annually in scientific research in Japan, member countries of the European Economic Community and Switzerland. Replacement can occur solely through imports, and figures for the UK and USA are shown in Table 2 . The turnover figures for the UK reported by Hobbs (1975) show a substantial decrease in 1975, consistent with the decrease in imports for scientific research. However, Hobbs also reports a turnover figure of 11 990 as an average per annum for 1968-1971; this is an average of the total imports for these years (Hobbs & Bleby, 1976) . The difference between total import figures and those for scientific research has already been discussed.
Japan's figures for laboratory use of primates are the numbers applied to experiments. In France the reverse occurred. The UK and USA figures for the number of primates applied to biomedical experiments correlate with the number of primates imported for that purpose. It is advisable to remember that figures for use have limited significance as they are the results of surveys, but they can be employed for discussing trends, especially in relation to species and areas of research use. Table 4 lists the numbers of various species applied to research. In Denmark and Belgium, the species most commonly used is the vervet, but in all other countries covered in the Table the major species is a macaqueeither rhesus or cynomolgus.
Species used in research
Numerical information on the species used for research in Japan is not available, but Honjo & Nomura (1972) discussed species composition of the 2,548 primates purchased by major institutions. They gave the order of use as cynomolgus, rhesus, patas and, finally, Japanese macaque. All are Old World monkeys. .,., <X) .,., role in the history of primate use in research, and still accounts for the majority of primates used (Table 5 ). It is unusual that it formed such a small fraction of the demand in Switzerland, considering that Ciba-Geigy, the Swiss Serum and Vaccine Institute, and HotTman-La-Roche all returned questionnaires.
Areas of research use Vaccine preparation and testing played an important
Vaccine preparation and testing also formed a smaller fraction of research use in the USA, with pharmacology and toxicology as the largest area, and disease programmes next. This is probably a result of America always having had so many primates to work with that more could be diverted into other fields such as toxicology.
According to Japanese purchase figures, vaccine preparation and testing was the largest area using primates, followed by pharmacology and toxicology programmes (Honjo & Nomura, 1972) .
Changing the primate situation This report presents the information available on primate use. Despite its limitations it is still possible to discuss trends. Numbers imported have dropped considerably in the last few years, and this situation is likely to continue.
To overcome the problems associated with using imported animals they can be specially bred or alternative systems can be employed. A number of surveys have recommended that primates should be bred, but this has become economically feasible only as the price of the imported animal has increased due to decreased supply and strict quarantine regulations.
Marmosets and tamari!ls, which are New World species. are relatively easy to breed, but it is now generally agreed that any of the commonly used species of research primate can be bred in captivity. Germany is breeding many rhesus macaques, marmosets, tamarins and prosimians and this is reflected in the ditTerences between the 1973-4 and 1976-7 figures (Table 4 ). In fact, it is not just the importing countries that are turning to breeding, for Peru, after representations from major user countries, has set up breeding centres where Saguinus mystax and Saimuri sciureus are reared. It is expected that 6500 primates will be exported in 1982, of which 1000 will come from the Breeding Centre and 5500 from Managed Areas (J. A. Burton, personal communication, 1978) . The other solution is the use of alternative systems. For example, alternatives have been etTective in vaccine production, where human diploid cultured cells and embryonated duck or chicken eggs have, to some extent, replaced primary kidney tissue cells cultured from primates and other animals. Vaccines for polio, measles, rubella and adenovirus, which all involved primates at one stage, can now be prepared (that is, the virus grown) in alternative systems, and those for adenovirus and rabies can be tested in such systems (Pratt, 1976) . It is very likely that human ingenuity could find adequate alternatives to replace primates in other areas, and it is the purpose of FRAME's survey to identify those areas where there are some prospects for developing useful and practical alternative systems.
Finally, it is necessary to reemphasize the difficulties involved in assessing the trends in primate use and availability. Those collecting information on this topic should carefully define the term 'use' and describe the limits of the information provided. Relevant international organizations such as ICLA should attempt to standardize the methods and terms adopted in laboratory animal surveys so as to increase the validity of comparisons between ditTerent countries and ditTerent years.
